{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:09:59Z","timestamp":1792289399262,"version":"4.4.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec id=\"ab-soi230062-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Circumferential resection margin (CRM) in rectal cancer surgery is a major prognostic indicator associated with local recurrence and overall survival. Facility rates of CRM positivity have recently been established as a new quality measure by the Commission on Cancer (CoC); however, the completeness of CRM status reporting is not well characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the changes in CRM reporting and factors associated with low rates of reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using data from the National Cancer Database between January 2010 and December 2019. Data were analyzed between October 1, 2021, and February 1, 2022. Data from the National Cancer Database included patients diagnosed with nonmetastatic rectal adenocarcinoma receiving surgical treatment at CoC-accredited facilities throughout the US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Patient, tumor, and facility-level factors. Facilities were divided by surgical volume, safety-net status, and CoC facility type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Circumferential resection margin missingness rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 110\u202f571 patients (59.3% men) with rectal adenocarcinoma who underwent curative-intent surgery at 1307 CoC-accredited hospitals were included for analysis. Reporting of CRM improved over the study period, with a mean (SE) missing 12.0% (0.32%) decreased from 16.3% (0.36%). Academic facilities had a higher missingness than other facility types (14.3% vs 10.5%-12.7%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Mean (SE) rates of missingness were similar between hospitals of varying volume (lowest quartile: 12.2% [0.93%] vs highest quartile: 12.4% [0.53%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.96). Cases in which fewer than 12 lymph nodes were removed had higher rates of missingness (18.1% vs 11.4%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Increased odds of CRM missingness were noted with T category (odds ratio [OR], 1.50; 95% CI, 1.35-1.65) and N category (OR, 2.00; 95% CI, 1.82-2.20). Black race was associated with missingness (OR, 1.13; 95% CI, 1.06-1.14).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi230062-10\">\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>Although CRM positivity reporting has improved over the last decade, the findings of this study suggest there is substantial room for improvement as it becomes a quality standard. Missingness appears to be associated with poor performance on other quality metrics and facility type. This measure appears to be ideal for targeted institution-level feedback to improve quality of care nationally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2023.4221","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:09:13Z","timestamp":1695208153000},"page":"1195","source":"Crossref","is-referenced-by-count":16,"title":["Reporting of Circumferential Resection Margin in Rectal Cancer Surgery"],"prefix":"10.1001","volume":"158","author":[{"given":"Naveen","family":"Manisundaram","sequence":"first","affiliation":[{"name":"Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Surgery, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"DiBrito","sequence":"additional","affiliation":[{"name":"Department of Surgery, Albany Medical College, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wick","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Palis","sequence":"additional","affiliation":[{"name":"The American College of Surgeons and the National Cancer Database"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peacock","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9666","key":"soi230062r1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","article-title":"Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.","volume":"373","author":"Quirke","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"soi230062r2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/bjs.1800821002","article-title":"Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus.","volume":"82","author":"Heald","year":"1995","journal-title":"Br J Surg"},{"issue":"9","key":"soi230062r3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"issue":"36","key":"soi230062r5","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.1200\/JCO.2005.02.9231","article-title":"Low rectal cancer: a call for a change of approach in abdominoperineal resection.","volume":"23","author":"Nagtegaal","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"soi230062r6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.0007-1323.2001.02024.x","article-title":"Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.","volume":"89","author":"Wibe","year":"2002","journal-title":"Br J Surg"},{"issue":"2","key":"soi230062r7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1245\/s10434-006-9171-0","article-title":"Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.","volume":"14","author":"Baik","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"soi230062r8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1200\/JCO.2007.12.7027","article-title":"What is the role for the circumferential margin in the modern treatment of rectal cancer?","volume":"26","author":"Nagtegaal","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"soi230062r9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","article-title":"Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.","volume":"26","author":"Nagtegaal","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"soi230062r10","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1097\/SLA.0000000000005302","article-title":"Circumferential resection margin is associated with distant metastasis after rectal cancer surgery: a nation-wide population-based study cohort.","volume":"277","author":"Agger","year":"2023","journal-title":"Ann Surg"},{"key":"soi230062r11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fonc.2020.00655","article-title":"Quality assurance, metrics, and improving standards in rectal cancer surgery in the United States.","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"soi230062r12","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s11605-020-04804-2","article-title":"Association of adherence to quality metrics with recurrence or mortality among veterans with colorectal cancer.","volume":"25","author":"Edwards","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"soi230062r13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jss.2018.11.040","article-title":"Using a lymph node count metric to identify underperforming hospitals after rectal cancer surgery.","volume":"236","author":"Raoof","year":"2019","journal-title":"J Surg Res"},{"issue":"6","key":"soi230062r14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/SLA.0000000000002003","article-title":"National Quality Forum colon cancer quality metric performance.","volume":"266","author":"Mason","year":"2017","journal-title":"Ann Surg"},{"issue":"7","key":"soi230062r15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5858\/2000-124-0979-PFICC","article-title":"Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999.","volume":"124","author":"Compton","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"soi230062r17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"soi230062r18","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s11605-020-04744-x","article-title":"Racial disparities in treatment for rectal cancer at minority-serving hospitals.","volume":"25","author":"Lu","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"soi230062r19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamasurg.2015.3209","article-title":"Effect of hospital safety-net burden on cost and outcomes after surgery.","volume":"151","author":"Hoehn","year":"2016","journal-title":"JAMA Surg"},{"key":"soi230062r20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jss.2017.08.047","article-title":"Hospital safety-net burden does not predict differences in rectal cancer treatment and outcomes.","volume":"221","author":"Hoehn","year":"2018","journal-title":"J Surg Res"},{"key":"soi230062r21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jss.2021.03.012","article-title":"Patient factors limit colon cancer survival at safety-net hospitals: a national analysis.","volume":"264","author":"Hrebinko","year":"2021","journal-title":"J Surg Res"},{"issue":"9","key":"soi230062r22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.6004\/jnccn.2015.0136","article-title":"Reduced circumferential resection margin involvement in rectal cancer surgery: results of the Dutch Surgical Colorectal Audit.","volume":"13","author":"Gietelink","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"soi230062r23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1245\/s10434-019-07323-w","article-title":"Compliance with cancer quality measures over time and their association with survival outcomes: the Commission on Cancer\u2019s experience with the quality measure requiring at least 12 regional lymph nodes to be removed and analyzed with colon cancer resections.","volume":"26","author":"Shulman","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"soi230062r24","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/JHQ.0000000000000225","article-title":"voluntary hospital reporting of performance in cancer care: does volume make a difference?","volume":"42","author":"Jin","year":"2020","journal-title":"J Healthc Qual"},{"issue":"27","key":"soi230062r25","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1200\/JCO.2014.55.5334","article-title":"Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.","volume":"32","author":"Massarweh","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"soi230062r26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/jnci\/djaa182","article-title":"Racial disparities in recurrence and overall survival in patients with locoregional colorectal cancer.","volume":"113","author":"Snyder","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"soi230062r4","doi-asserted-by":"crossref","unstructured":"van Gijn? WM, Marijnen? CA, Nagtegaal? ID, . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. 2011;12:575-582. doi:10.1016\/S1470","DOI":"10.1016\/S1470-2045(11)70097-3"},{"key":"soi230062r16","unstructured":"Commission on Cancer. RCRS System Upgrade Update. March 3, 2022. Accessed April 24, 2023. https:\/\/www.facs.org\/for-medical-professionals\/news-publications\/news-and-articles\/cancer-programs-news\/030322\/coc\/"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2809850\/jamasurgery_manisundaram_2023_oi_230062_1699372311.92099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:05:14Z","timestamp":1699441514000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2809850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.4221","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}